Literature DB >> 31951587

Organoids as Oracles for Precision Medicine in Rectal Cancer.

Kevin S Kolahi1, Michitaka Nakano2, Calvin J Kuo3.   

Abstract

Two recent papers in Cell Stem Cell and Nature Medicine (Yao et al. [2019] and Ganesh et al. [2019]) demonstrate the successful use of rectal cancer patient-derived organoids to predict patient responses to neoadjuvant chemoradiation therapy, paving the way toward a new paradigm for precision medicine.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID： 31951587     DOI： 10.1016/j.stem.2019.12.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  6 in total

Review 1.  Harnessing the predictive power of preclinical models for oncology drug development.

Authors:  Alexander Honkala; Sanjay V Malhotra; Shivaani Kummar; Melissa R Junttila
Journal:  Nat Rev Drug Discov       Date:  2021-10-26       Impact factor: 84.694

2.  Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients.

Authors:  Khamushavalli Geevimaan; Jing-You Guo; Chia-Ning Shen; Jeng-Kai Jiang; Cathy S J Fann; Ming-Jing Hwang; Jr-Wen Shui; Hsiu-Ting Lin; Mei-Jung Wang; Hsuan-Cheng Shih; Anna Fen-Yau Li; Shih-Ching Chang; Shung-Haur Yang; Jeou-Yuan Chen
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

Review 3.  Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models.

Authors:  Moying Li; Qiyun Xiao; Nachiyappan Venkatachalam; Ralf-Dieter Hofheinz; Marlon R Veldwijk; Carsten Herskind; Matthias P Ebert; Tianzuo Zhan
Journal:  Ther Adv Med Oncol       Date:  2022-02-21       Impact factor: 8.168

4.  Assessment of source material for human intestinal organoid culture for research and clinical use.

Authors:  Paulo C M Urbano; Hamish C K Angus; Safina Gadeock; Michael Schultz; Roslyn A Kemp
Journal:  BMC Res Notes       Date:  2022-02-10

Review 5.  Tumor organoids: applications in cancer modeling and potentials in precision medicine.

Authors:  Hanxiao Xu; Dechao Jiao; Aiguo Liu; Kongming Wu
Journal:  J Hematol Oncol       Date:  2022-05-12       Impact factor: 23.168

6.  Enteroaggregative E. coli Adherence to Human Heparan Sulfate Proteoglycans Drives Segment and Host Specific Responses to Infection.

Authors:  Anubama Rajan; Matthew J Robertson; Hannah E Carter; Nina M Poole; Justin R Clark; Sabrina I Green; Zachary K Criss; Boyang Zhao; Umesh Karandikar; Yikun Xing; Mar Margalef-Català; Nikhil Jain; Reid L Wilson; Fan Bai; Joseph M Hyser; Joseph Petrosino; Noah F Shroyer; Sarah E Blutt; Cristian Coarfa; Xuezheng Song; Bv Venkataram Prasad; Manuel R Amieva; Jane Grande-Allen; Mary K Estes; Pablo C Okhuysen; Anthony W Maresso
Journal:  PLoS Pathog       Date:  2020-09-28       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.